More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...

More than half of adults with overweight or obesity prescribed a GLP-1 discontinue their drug within 1 year, with discontinuation rates higher for those without type 2 diabetes, researchers reported ...

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

A new study finds that three quarters of American adults and half of adolescents are too heavy. That's making more of us sick and creating enormous health care costs.

A group of 58 researchers is calling for a new, better way to measure obesity and excess body fat that goes beyond BMI.

Obesity has been an ongoing struggle for many consumers, and for years, body mass index (BMI) has been the key metric health ...

Researchers identify a significant association between sugar-sweetened beverage tax and BMI changes among adults living in ...

Both Roux-en-Y gastric bypass and sleeve gastrectomy reduced health care expenditures after surgery for adults with type 2 ...

A study found that the triglyceride-glucose (TyG) index, combined with obesity measures, significantly correlates with ...

Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy ...

New poll reveals Americans' mixed views on weight-loss drugs for obesity treatment, especially regarding teen use.